Data in Table S1 demonstrate that in oral cancer tissues LOXL2 was by far the most significantly upregulated LOX paralogue (9.8-fold), while other paralogues were modestly upregulated (1.6–2.3-fold). This evidence concerns the gene LOX and lip and oral cavity carcinoma.